| Dr Kevin H Komadina, MD | |
|
6490 Excelsior Blvd, Ste W300, St Louis Park, MN 55426-4705 | |
| (952) 993-3242 | |
| Not Available |
| Full Name | Dr Kevin H Komadina |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 6490 Excelsior Blvd, St Louis Park, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487639662 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 34405 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin H Komadina, MD 6465 Wayzata Blvd, Ste 315, St Louis Park, MN 55426-1728 Ph: () - | Dr Kevin H Komadina, MD 6490 Excelsior Blvd, Ste W300, St Louis Park, MN 55426-4705 Ph: (952) 993-3242 |
News Archive
At the University of Copenhagen, researchers have discovered how some types of proteins stabilize damaged DNA and thereby preserve DNA function and integrity. This new finding also explains why people with inborn or acquired defects in certain proteins cannot keep their DNA stable and develop diseases such as cancer.
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.
Medicago, a leading company in the development and production of plant-based vaccines and therapeutics, announced today that it has received a task order from the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services for three anti-Ebola virus monoclonal antibodies (mAbs) with expected performance comparable to that of ZMapp, from Mapp Biopharmaceutical.
Examiner: "House Speaker Nancy Pelosi (D-CA) intends to bring the legislation to the floor early this week, but Pro-life Representative Bart Stupak (D-MI) and a posse of conservative Democrats might just throw a wrench in Pelosi's plans.
Scientists have developed a new drug (RPL554) that could treat obstructive airway diseases such as asthma and chronic obstructive pulmonary disease in two ways at once, according to new research published in The Lancet Respiratory Medicine.
› Verified 1 days ago
Cara Houle, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6500 Excelsior Blvd, St Louis Park, MN 55426 Phone: 952-993-5000 | |
Janet Grayson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6500 Excelsior Blvd, St Louis Park, MN 55426 Phone: 952-993-6600 | |
Keith Harmon, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6490 Excelsior Blvd, Suite W300, St Louis Park, MN 55426 Phone: 952-993-3242 | |
Jeffrey J Shultz, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6500 Excelsior Blvd, Park Nicollet Clinic - Heart & Vascular Center, St Louis Park, MN 55426 Phone: 952-993-3246 Fax: 952-993-3010 | |
Amanda J Calvin, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3931 Louisiana Ave S, St Louis Park, MN 55426 Phone: 952-993-3230 | |
Sarah Evert, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3850 Park Nicollet Blvd, St Louis Park, MN 55416 Phone: 952-993-3025 | |
Stevie Maxwell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6500 Excelsior Blvd, St Louis Park, MN 55426 Phone: 952-993-5000 |